Jefferies Reiterates a 'Buy' on Health Management (HMA); Adjusting Estimates and PT After Q1 Results

Article Stock Quotes (1) Comments (0)

Jefferies reiterates a 'Buy' on Health Management (NYSE: HMA) price target lowered from $11 to $10.

Analyst, Arthur I. Henderson, said, "HMA posted a respectable $0.01 earnings beat in Q1 and reiterated its FY12 EPS outlook of $0.80-$0.90. While weak SS admissions may irk some investors, HMA captured robust outpatient volumes and good pricing-- both of which helped to offset this headwind. At 5.8x FY12 EBITDA, HMA remains attractively valued, in our opinion."

Jefferies lowers FY12 EPS estimate from $1.08 to $0.87 and FY13 from $1.08 to $0.97. FY12 revs cut from $6,455.3mln to $5,652.3mln and FY13 from $6,624.2mln to $5,877.1mln.

For an analyst ratings summary and ratings history on Health Management click here. For more ratings news on Health Management click here.

Shares of Health Management closed at $7.15 yesterday, with a 52 week range of $4.81-$11.74.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Wells Fargo Downgrades Aruba Networks (ARUN) to Market Perform
• Deutsche Bank Takes Aegerion (AEGR) Price Target from $52 to $85

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?